Unlikely to cause harm — often a labeling or packaging issue.
Subpotent drug
| Brand name | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
| Generic name | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
| Active ingredient(s) | AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM TRIHYDRATE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 43598-321-30 |
| Full product label | Amlodipine besylate and Atorvastatin calcium tablets, 10mg/10mg, packaged in a)30-count bottle (NDC 43598-321-30), b) 90-count bottle (NDC 43598-321-90), Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | Nationwide |
| Recall initiated | 2015-05-06 |
| Report date | 2015-06-24 |
| Recall completed | 2016-03-31 |
| Recall number | D-1144-2015 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗